ClinicalTrials.gov
public full text
Public Domain
The Letrozole Administration During Luteal Phase
To investigate the effect of letrozole in patients who have high risk of ovarian hyperstimulation syndrome (OHSS) after oocyte retrieval, the incidence of OHSS were calculated between letrozole group and supporting treatment group.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Outpatient paracentesis for Ovarian Hyperstimulation Syndrome: STOP-OHSS feasibility study and RCT Synopsis#218718
- Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction#1165215
- Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.#873258
- A Comparison of Letrozole and Clomifene Citrate#865639
- Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome#628520
Record · ID 1008851
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive